FDA boosts generics
June 22, 2016
In WHAT may prove to be a
significant precedent, the US Food
and Drug Administration (FDA)
has won a case in the US Supreme
Court where in an attempt to limit
drug prices, according to a report
from Modern Healthcare.
The Supreme Court decided
Monday in a patent case not
actually relating to drugs, but
potentially precedential, to affirm
a lower court ruling allowing the
U.S. Patent and Trademark Office’s
Patent Trial and Appeal Board to
continue using a broader standard
than federal courts when it comes
to interpreting patent claims.
In 2011, Congress began allowing
patent challengers to take their
fight before the board, rather than
to federal court, as an alternative
to costly, time-consuming court
battles.
The result may have implications
across many industries wherever
patents and innovation matter, the
article said.
The above article was sent to subscribers in Pharmacy Daily's issue from 22 Jun 16To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 22 Jun 16
